Ruthenium polypyridyl complexes and their modes of interaction with DNA: Is there a correlation between these interactions and the antitumor activity of the compounds?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Various interaction modes between a group of six ruthenium polypyridyl complexes and DNA have been studied using a number of spectroscopic techniques. Five mononuclear species were selected with formula [Ru(tpy)L ₁L ₂] ^{(2−
n)+}, and one closely related dinuclear cation of formula [{Ru(apy)(tpy)} ₂{μ-H ₂N(CH ₂) ₆NH ₂}] ⁴⁺. The ligand tpy is 2,2′:6′,2″-terpyridine and the ligand L ₁ is a bidentate ligand, namely, apy (2,2′-azobispyridine), 2-phenylazopyridine, or 2-phenylpyridinylmethylene amine. The ligand L ₂ is a labile monodentate ligand, being Cl ⁻, H ₂O, or CH ₃CN. All six species containing a labile L ₂ were found to be able to coordinate to the DNA model base 9-ethylguanine by ¹H NMR and mass spectrometry. The dinuclear cationic species, which has no positions available for coordination to a DNA base, was studied for comparison purposes. The interactions between a selection of four representative complexes and calf-thymus DNA were studied by circular and linear dichroism. To explore a possible relation between DNA-binding ability and toxicity, all compounds were screened for anticancer activity in a variety of cancer cell lines, showing in some cases an activity which is comparable to that of cisplatin. Comparison of the details of the compound structures, their DNA binding, and their toxicity allows the exploration of structure–activity relationships that might be used to guide optimization of the activity of agents of this class of compounds.

Electronic supplementary material

The online version of this article (doi:10.1007/s00775-008-0460-x) contains supplementary material, which is available to authorized users.

Related collections

Most cited references 62

Record: found
Abstract: found
Article: not found

How to study proteins by circular dichroism.

Sharon Kelly, Thomas Jess, Nicholas C. Price (2005)

Circular dichroism (CD) is being increasingly recognised as a valuable technique for examining the structure of proteins in solution. However, the value of many studies using CD is compromised either by inappropriate experimental design or by lack of attention to key aspects of instrument calibration or sample characterisation. In this article, we summarise the basis of the CD approach and its application to the study of proteins, and then present clear guidelines on how reliable data can be obtained and analysed.

0 comments Cited 541 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: not found
Article: not found

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

Elizabeth Jamieson, Stephen Lippard (1999)

0 comments Cited 315 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

M Alley, D Scudiero, A. Monks … (1988)

For the past 30 years strategies for the preclinical discovery and development of potential anticancer agents have been based largely upon the testing of agents in mice bearing transplantable leukemias and solid tumors derived from a limited number of murine as well as human sources. The feasibility of implementing an alternate approach, namely combined in vitro/in vivo screening for selective cytotoxicity among panels of human tumor cell lines derived from a broad spectrum of human solid tumors is under investigation. A group of 30 cell lines acquired from a variety of sources and representing 8 lung cancer pathologies as well as 76 cell lines representing 10 other categories of human cancer (carcinomas of colon, breast, kidney, prostate, ovary, head and neck; glioma; leukemia; melanoma; and sarcoma) have exhibited acceptable growth characteristics and suitable colorimetric profiles in a single, standard culture medium. Measurements of in vitro growth in microculture wells by cell-mediated reduction of tetrazolium showed excellent correlation (0.89 less than r2 less than 0.98) with measurements of cellular protein in adherent cell line cultures as well as viable cell count in suspension cell line cultures (0.94 less than r2 less than 0.99). Since the microculture tetrazolium assay provides sensitive and reproducible indices of growth as well as drug sensitivity in individual cell lines over the course of multiple passages and several months' cultivation, it appears suitable for initial-stage in vitro drug screening.